Skip to main content
. 2023 Sep 26;9(1):69–77. doi: 10.1177/23969873231201715

Table 1.

Characteristics of the included studies.

Study ID Study design Occlusion site, N (%) No. of patients (% female)
Baseline NIHSS, Median (IQR)
IVT, N (%)
ENI definition sICH definition
EVT BMM EVT BMM EVT BMM
Cunha et al. 2 Single-center retrospective cohort P1: 19 (50%), P2: 16 (42.1%), P3: 3 (7.89%) 25 (36.0) 13 (46.2) 10 (6–14.5) 8 (5.5–10.0) 14 (56) 13 (100) A minimum four-point score improvement compared to admission NIHSS. ECASS II
Herweh et al. 10 Multicenter retrospective cohort P1: 62 (47.69%), distal to P1: 68 (52.3%) 23 (39.1) 107 (47.7) 9 (1–20) 7 (1–38) 5 (21.7) 44 (41.1) An improvement in NIHSS scores of at least 4 points or reaching 0 points. Heidelberg Bleeding Classification
Maulucci et al. 17 Multicenter retrospective cohort P1: 107 (39.9%), P2: 161 (60.1%) 119 (35.3) 149 (45.6) 7 (5–13) 5 (3–8) 69 (57.98) 149 (100) ECASS II
Meyer et al. 12 Multicenter retrospective case-control P2: 199 (81.9%), P3: 44 (18.1%), fetal variant 15 (6.2%), bilateral 8 (3.3%) 143 (44.8) 100 (50.0) 7 (4–11) 5 (2–10) 57 (39.9) 56 (56.0) An improvement in NIHSS scores of at least 4 points or reaching 0 points. ECASS II
Nguyen et al. 6 Multicenter retrospective cohort P1: 421 (41.2%), P2: 503 (49.2%), P3 (includes 3 P4): 73 (7.1%), fetal PCA: 14 (1.4%), bilateral: 12 (1.2%) 378 (42.9) 645 (42.2) 8 (5–12) 5 (2–9) 152 (40.2) 287 (45.5) A ⩾ 2-point decrease in (NIHSS) at 24 h or at hospital discharge. SITS-MOST
Sabben et al. 9 Multicenter retrospective cohort P1: 188 (25%), P2: 564 (75%) 167 (47.3) 585 (42.7) 8 (5–11) 6 (3–10) 90 (53.9) 467 (79.8) ECASS II
Strambo et al. 3 Single-center retrospective cohort P1: 34 (32.1%; n = 3 fetal), P2: 72 (67.9%; n = 4 fetal) 21 (61.9) 85 (43.5) 7 (5–8.3) 7 (4–12.0) 13 (61.9) 34 (40) ECASS II

iPCAO: isolated posterior cerebral artery occlusion; EVT: endovascular thrombectomy; BMM: best medical management; IVT: intravenous thrombolysis; NIHSS: National Institutes of Health Stroke Scale; ENI: early neurological improvement; ECASS II: European Cooperative Acute Stroke Study-II; SITS-MOST: Safe Implementation of Thrombolysis in Stroke-Monitoring Study.